These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12829656)

  • 1. Insulin acutely increases fibrinogen production in individuals with type 2 diabetes but not in individuals without diabetes.
    Barazzoni R; Kiwanuka E; Zanetti M; Cristini M; Vettore M; Tessari P
    Diabetes; 2003 Jul; 52(7):1851-6. PubMed ID: 12829656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria.
    Tessari P; Kiwanuka E; Millioni R; Vettore M; Puricelli L; Zanetti M; Gucciardi A; Tosolini M; Cogo P; Carnielli V; Tiengo A; Barazzoni R
    Diabetes Care; 2006 Feb; 29(2):323-8. PubMed ID: 16443881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen kinetics and protein turnover in obese non-diabetic males: effects of insulin.
    Tessari P; Cosma A; Vettore M; Millioni R; Puricelli L; Cogo P; Cecchet D; Carnielli V; Kiwanuka E
    Diabetes Metab Res Rev; 2010 Jan; 26(1):50-8. PubMed ID: 19943326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fibrinogen production in type 2 diabetic patients without detectable vascular complications: correlation with plasma glucagon concentrations.
    Barazzoni R; Zanetti M; Davanzo G; Kiwanuka E; Carraro P; Tiengo A; Tessari P
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3121-5. PubMed ID: 10999796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen kinetics and protein turnover in hypertension: Effects of insulin.
    Kiwanuka E; Coracina A; Vettore M; Semplicini A; Zaramella M; Millioni R; Puricelli L; Baiocchi MR; Tessari P
    Nutr Metab Cardiovasc Dis; 2009 Dec; 19(11):789-96. PubMed ID: 19346115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of fatty acids on hepatic amino acid catabolism and fibrinogen synthesis in young healthy volunteers.
    Freyse EJ; Giessmann T; Petzke KJ; Knospe S; Engel G; Heinke P; Metges CC; Siegmund W
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E54-62. PubMed ID: 12791602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic nephropathy is associated with increased albumin and fibrinogen production in patients with type 2 diabetes.
    Tessari P; Kiwanuka E; Barazzoni R; Vettore M; Zanetti M
    Diabetologia; 2006 Aug; 49(8):1955-61. PubMed ID: 16703327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin infusion normalizes fasting and post-prandial albumin and fibrinogen synthesis in Type 1 diabetes mellitus.
    Bruttomesso D; Iori E; Kiwanuka E; Zanetti M; Pianta A; Vettore M; Tiengo A; Tessari P
    Diabet Med; 2001 Nov; 18(11):915-20. PubMed ID: 11703437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin effect on leucine kinetics in type 2 diabetes mellitus.
    Halvatsiotis PG; Turk D; Alzaid A; Dinneen S; Rizza RA; Nair KS
    Diabetes Nutr Metab; 2002 Jun; 15(3):136-42. PubMed ID: 12173727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
    Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
    Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes.
    Basu R; Basu A; Johnson CM; Schwenk WF; Rizza RA
    Diabetes; 2004 Aug; 53(8):2042-50. PubMed ID: 15277384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes.
    Lewis GF; Carpentier A; Vranic M; Giacca A
    Diabetes; 1999 Mar; 48(3):570-6. PubMed ID: 10078558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.
    Basu A; Caumo A; Bettini F; Gelisio A; Alzaid A; Cobelli C; Rizza RA
    Diabetes; 1997 Mar; 46(3):421-32. PubMed ID: 9032098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of insulin action in NIDDM in the presence of dynamic changes in insulin and glucose concentration.
    Katz H; Homan M; Jensen M; Caumo A; Cobelli C; Rizza R
    Diabetes; 1994 Feb; 43(2):289-96. PubMed ID: 8288053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance of protein metabolism in type 2 diabetes.
    Pereira S; Marliss EB; Morais JA; Chevalier S; Gougeon R
    Diabetes; 2008 Jan; 57(1):56-63. PubMed ID: 17940118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and type 2 diabetes impair insulin-induced suppression of glycogenolysis as well as gluconeogenesis.
    Basu R; Chandramouli V; Dicke B; Landau B; Rizza R
    Diabetes; 2005 Jul; 54(7):1942-8. PubMed ID: 15983193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS; Elliott T
    Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased synthesis rate of fibrinogen as a basis for its elevated plasma levels in obese female adolescents.
    Balagopal P; Sweeten S; Mauras N
    Am J Physiol Endocrinol Metab; 2002 Apr; 282(4):E899-904. PubMed ID: 11882510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.